ABB is first in world to offer a magnet-free IE6 motor for hazardous areas
Boosting energy efficiency in hazardous areas is critical for operators seeking to reduce their operating costs while also…
ABB is first in world to offer a magnet-free IE6 motor for hazardous areas
Boosting energy efficiency in hazardous areas is critical for operators seeking to reduce their operating costs while also…
Swiss Water Reports First Quarter 2026 Results
VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or…
Swiss Water Conference Call Notification for 2026 First Quarter Results
VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX: SWP) (“Swiss Water”…
Hoskin off to conquer Australia after Geneva earns Derby tilt
“The plan was to fly over here and then head up to Aaron Bain’s at the old Lindsay…
Geneva College of Longevity Science Launches the World’s First PhD in Longevity Sciences
GENEVA and CONSTANȚA, Romania, April 24, 2026 (GLOBE NEWSWIRE) — The Geneva College of Longevity Science (GCLS) today…
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
Phase III METEOROID study met its primary endpoint in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)MOGAD is…
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4…
Swiss Sportswear Giant On Unveils First Standalone Store in Seoul, Invigorating South Korea’s Retail Scene
Swiss sportswear label, On, has unveiled its inaugural standalone shop in South Korea, furthering its direct-to-consumer reach within…
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1…